Alger Ai Enablers and Adopters ETF (ALAI) News

Fridays filing fwiw:
https://www.otcmarkets.com/filing/html?id=18167517&guid=mf0-kqyAqwruQOh

Nice, dear. And today a federal judge gave Musk and his DOGEbags the smackdown they've been asking for.

So one of those DOGEbags spent a good deal of time posting on the social media, "I was a white supremacist before it was cool!" and other repellent stuff. Musk chuckled and said boy

"As of December 31, 2023, there was $2,617,211 in loan interest"

nope...there was $1.6 mil in outstanding LOANS (not interest)...

"As of December 31, 2024, there was a preliminary and unaudited $304,545 in loan interest"

correct...$304,545 in INTEREST acc

Thia account is suspended until Nov 2027

Exactly.

By the way, I just watched that video. What on earth presumably makes you believe I think this country is okay, and going in the right direction?

I should have imagined that you'd understood from my many posts that I think we're headed to hell in a handbasket. Unlike you, I do not fe

this bill is on the current Congress' calender to be discussed sometime before the end of Feb

Shown Here:
Introduced in Senate (03/28/2023)

Setting Consumer Standards for Lithium-Ion Batteries Act

This bill requires the Consumer Product Safety Comm

It's nearly March. This stock has a history of running hard in March. First the float gets soaked up cheap which we have been seeing happening. Next, the Company will put out press and other media. Watch for this as they have been silent. Then boom, a run. As Florida stated he ran this from down her

Shown Here:
Introduced in Senate (03/28/2023)

Setting Consumer Standards for Lithium-Ion Batteries Act

This bill requires the Consumer Product Safety Commission to issue a consumer product safety standard for rechargeable lithium-ion batteries used in micromobili

Remember Buffett's Famous Fannie Fumble -
How he always wanted to own "The Lion's Share,"
of FNMA...Aah, What Might Have Been - What
Could Have Been....now gone...or is it?

Some guys in one of my groups were talking about a major partnership with Ecite that will put this worldwide. Supposedly a bigger player than Lucid.

Looks to me like a lot of neo fascist, antisemitic claptrap, but hey, I guess I'm just too old to appreciate the return of Mussolini in the form of Orban.

Nonetheless, I'm the one with the Ph.D., not you.

You are correct, Honore has no use for Trump.

No matter who wins the Super Bowl, POSRMX bag holders are still the losers, and we all know who the biggest one is after “borrowing” all those shares……

Fly Eagles Fly

Lie Maxine Li-e






.

It's a very clear choice all over the world, globalism and the great reset.......vs. the great awakening. If you've read any Russian philosophy or heck Russian writing for that matter i.e. Dostoevsky. You're amazed at the brilliance of these people. Maybe that's why they're so good at chess. At any

Jab that is a shame I'm sure I've told this before, Sprycell posted on the Tell board many times about TGLO in the spring of 2018. I remember on a Saturday coming to the TGLO board spending a lot of time reading back posts trying to do DD it was hard not a lot of info outside of the board. The feeli

👍️😂😉

West Virginia, the most obese state, now can’t afford weight loss drugs
https://www.wtrf.com/west-virginia/west-virginia-the-most-obese-state-now-cant-afford-weight-loss-drugs/

West Virginia: Most fentanyl overdoses, most obese, most uneducated, most illiterate, worst infrastr

I have not. But I can guarantee you I would be repelled by what Dugin stands for.

What? I've never told anyone how to raise kids. As an only child, the only thing I know about children is what I know because I once was one.

Though I admit I'm sometimes surprised by what many parents have evidently forgotten about that. For example, that if you get all huffy and st

The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t